NYSE$ZTS
Zoetis · Q3 2020 earnings
Q3 2020 earnings · · Investor relations
Briefing
Reported revenue of $1.8 billion, growing 13%, and net income of $479 million, or $1.00 per diluted share, both increasing 11% for the third quarter of 2020.
Zoetis reported a strong third quarter in 2020, with revenue reaching $1.8 billion, a 13% increase compared to the previous year. Net income also saw an 11% increase, amounting to $479 million, or $1.00 per diluted share. The company's companion animal business was a key driver of growth, and livestock also contributed positively, especially in the U.S. cattle and China's swine markets. Due to the strong performance, Zoetis is increasing its full-year guidance for 2020.
- Revenue reached $1.8 billion, a 13% increase year-over-year.
- Net income increased by 11% to $479 million, or $1.00 per diluted share.
- Adjusted net income was $524 million, or $1.10 per diluted share.
- Companion animal products, particularly Simparica Trio and key dermatology products, drove sales growth.
Headline financials
Revenue & EPS history
Zoetis · Revenue · Quarterly
$1.79B
Revenue by segment
Zoetis · $1.79B total across 3 segments · Q3 2020
- Companion Animal$995M+19.3%55.7%
- Livestock$768M+5.1%43.0%
- Contract Mfg & Human Health$23M+21.1%1.3%
Forward guidance
Zoetis is increasing its full year 2020 guidance, including revenue between $6.550 billion and $6.625 billion, reported diluted EPS between $3.38 and $3.45, adjusted diluted EPS between $3.76 and $3.81.
Tailwinds
- Revenue between $6.550 billion and $6.625 billion
- Operational growth 7% to 8%
- Adjusted cost of sales as a percentage of revenue approximately 30%
- Adjusted SG&A expenses $1.615 to $1.645 billion
- Adjusted R&D expenses $455 to $465 million
Headwinds
- Adjusted interest expense and other (income)/deductions-net approximately $250 million
- Effective tax rate on adjusted income 19% to 20%
- Adjusted diluted EPS $3.76 to $3.81
- Adjusted net income $1.790 to $1.825 billion
- Operational growth 6% to 8%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2020
+0.4%
Avg return
Earnings day
-0.6%
Avg return
5 days after
+0.5%
Avg return
30 days after
55%
32 / 58 earnings
Positive
+8.1%
Q4 2018
Best reaction
-13.7%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.2% | -30.9% | -28.5% | |
| Q4 2025 | -2.4% | -2.4% | -10.1% | |
| Q3 2025 | -13.7% | -16.7% | -16.6% | |
| Q2 2025 | -3.7% | -2.9% | +0.9% | |
| Q1 2025 | -5.3% | +0.8% | +6.7% | |
| Q4 2024 | -5.1% | -10.0% | -7.3% | |
| Q3 2024 | -3.7% | -2.8% | -3.6% | |
| Q2 2024 | +5.7% | +6.0% | +6.7% | |
| Q1 2024 | +5.4% | +6.3% | +7.0% | |
| Q4 2023 | -6.4% | -4.2% | -11.6% | |
| Q3 2023 | +7.1% | +10.4% | +18.3% | |
| Q2 2023 | +4.8% | +5.6% | +3.9% | |
| Q1 2023 | +4.8% | +3.7% | -3.3% | |
| Q4 2022 | +7.3% | +5.4% | +1.9% | |
| Q3 2022 | -9.3% | -7.6% | +6.8% | |
| Q2 2022 | -3.1% | -5.9% | -12.9% | |
| Q1 2022 | -4.3% | -8.0% | -4.4% | |
| Q4 2021 | -0.7% | -2.6% | -1.4% | |
| Q3 2021 | +2.7% | +4.3% | +5.8% | |
| Q2 2021 | -1.4% | -2.9% | +2.4% | |
| Q1 2021 | -1.3% | -2.1% | +0.8% | |
| Q4 2020 | +1.3% | -4.0% | -8.6% | |
| Q3 2020 | -2.9% | -6.8% | -9.4% | |
| Q2 2020 | +0.7% | -0.5% | -0.3% | |
| Q1 2020 | -5.4% | -3.7% | +7.4% | |
| Q4 2019 | +0.8% | +0.5% | -12.2% | |
| Q3 2019 | -3.0% | -3.5% | +0.2% | |
| Q2 2019 | +7.4% | +11.1% | +13.8% | |
| Q1 2019 | +1.9% | -0.4% | -0.7% | |
| Q4 2018 | +8.1% | +7.5% | +9.8% | |
| Q3 2018 | +2.9% | +2.9% | +4.1% | |
| Q2 2018 | +6.5% | +7.5% | +5.3% | |
| Q1 2018 | -3.6% | -1.5% | +2.4% | |
| Q4 2017 | +7.1% | +7.9% | +13.6% | |
| Q3 2017 | +6.5% | +6.1% | +12.1% | |
| Q2 2017 | -1.6% | -3.4% | +4.9% | |
| Q1 2017 | +7.0% | +6.9% | +12.4% | |
| Q4 2016 | -4.8% | -3.0% | -2.1% | |
| Q3 2016 | +3.6% | +5.8% | +3.9% | |
| Q2 2016 | +3.4% | +2.2% | +3.1% | |
| Q1 2016 | +0.2% | — | — | |
| Q4 2015 | +3.4% | — | — | |
| Q3 2015 | +5.2% | — | — | |
| Q2 2015 | +0.3% | — | — | |
| Q1 2015 | -0.2% | — | — | |
| Q4 2014 | +4.3% | — | — | |
| Q3 2014 | +4.1% | — | — | |
| Q2 2014 | -2.8% | — | — | |
| Q1 2014 | +0.4% | — | — | |
| Q4 2011 | +0.1% | — | — | |
| Q4 2013 | -3.7% | — | — | |
| Q3 2012 | -0.5% | — | — | |
| Q3 2013 | -2.1% | — | — | |
| Q2 2012 | -1.4% | — | — | |
| Q2 2013 | -0.0% | — | — | |
| Q1 2012 | +0.9% | — | — | |
| Q4 2012 | +0.9% | — | — | |
| Q1 2013 | +2.2% | — | — | |
| Q3 2011 | — | — | — | |
| Q2 2011 | — | — | — | |
| Q1 2011 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro